Overview

Ankylosing Spondylitis Market Ois poised to register a CAGR of 4.6% during the forecast period 2022 to 2028.

The emergence of advanced products like biosimilars is the key factor responsible for the ankylosing spondylitis market growth. Furthermore, the growing prevalence of spondylitis owing to increased usage of smart phones, laptops and other electronic devices that enforce a strain on the spinal cord, lack of exercise and a sedentary lifestyle shall bolster the proliferation of the market. As per the data provided by the Oxford University Press, the number of patients in the European region have risen to over 1.5 million and over 4 million in the Asia Pacific region, with such a prevalence of spondylitis, the market is predicted to lead the market during the forecasted timeframe.

Major players included in the Ankylosing Spondylitis Market:

• AbbVie Inc.
• Janssen Pharmaceuticals Inc.
• Pfizer Inc.
• Sandoz International GmbH.
• Amgen Inc.
• Protalix BioTherapeutics, Inc.
• Reliance Life Sciences Pvt. Ltd.
• Momenta Pharmaceuticals Inc.
• Celgene Corporation
• Regeneron Pharmaceuticals
• Merck & Co. Inc.
• Johnson & Johnson Services, Inc.
• UCB Inc.
• Eli Lilly and Company
• Novartis AG
• Samsung Bioepis Co., Ltd.
• Biothera Pharmaceuticals, Inc (Note: The list of the major players will be updated with the latest market scenario and trends)

Ankylosing Spondylitis Market Segmentation:

By Drug
•   Cosentyx
•   Humira
•   Simponi
•   Remicade
•   Embrel
•   Cimzia

By Molecule Type
• Small Molecules
• Biologics
• Biosimilars

By Route of Administration
• Oral
• Parenteral

By End User
• Hospitals
• Clinics
• Others

By Region
•   North America
•   Europe
•   Asia Pacific
•   Latin America
•   Middle East & Africa

The market is categorized into drug, molecule type, route of administration, end user and region. The drug segment is fragmented into Cosentyx, Humira, Simponi, Enbrel and Cimzia. The Humira drug is estimated to hold the largest ankylosing spondylitis market share and this is credited to its high efficacy and low cost. The Cosentyx, however, it predicted to grow at a substantial rate during the forecasted timeframe owing to the expiration of patents in the European region. The end user segment is classified into hospitals, clinics and others.

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
•   Growth prospects
•   SWOT analysis
•   Key market trends
•   Key data-points affecting market growth

Objectives of the Study:
•   To provide with an exhaustive analysis on the Ankylosing Spondylitis Market By Drug, By Molecule Type, By Route of Administration, By End User and By Region.
•   To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•   To evaluate and forecast micro-markets and the overall market
•   To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•   To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

Flexible Delivery Model:
•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com